Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - TETRALOGIC PHARMACEUTICALS Corp | tlog-20151231ex311b5bbbb.htm |
| EX-31.2 - EX-31.2 - TETRALOGIC PHARMACEUTICALS Corp | tlog-20151231ex3121bf66d.htm |
| 10-K - 10-K - TETRALOGIC PHARMACEUTICALS Corp | tlog-20151231x10k.htm |
| EX-21 - EX-21 - TETRALOGIC PHARMACEUTICALS Corp | tlog-20151231ex21eb1443b.htm |
| EX-32.1 - EX-32.1 - TETRALOGIC PHARMACEUTICALS Corp | tlog-20151231ex3215d101d.htm |
| EX-32.2 - EX-32.2 - TETRALOGIC PHARMACEUTICALS Corp | tlog-20151231ex32253853e.htm |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement No. 333-192875 on Form S-8 and No. 333-201346 on Form S-3 of TetraLogic Pharmaceuticals Corporation of our report dated March 16, 2016, with respect to the consolidated financial statements of TetraLogic Pharmaceuticals Corporation included in this Annual Report (Form 10-K) for the year ended December 31, 2015.
/s/ Ernst & Young LLP
Philadelphia, Pennsylvania
March 16, 2016